LobbyingAssociation for Prescription Psychedelics lobbying by quarter
Association for Prescription Psychedelics's latest lobbying report covers Q2 2026, at $37.5K. The four quarters Q4 2025–Q3 2026 total $105K. Its first report covers Q3 2025; the issues it reports most are Health Issues.
Association for Prescription Psychedelics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $105K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $37.5K | 1 |
| Q2 2026 | $37.5K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$135K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
- Drug Enforcement Administration (DEA)1 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- Veterans Affairs, Dept of (VA)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Bose Public Affairs Group | $135K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DAVID CRANE | Senior Policy Advisor, Senate Majority Leader, Senate Republican Leader, Professional Staff, Senate Commerce Committee, Legislative Director, Senator Dan Coats, Legislative Assistant Senator Dan Coats | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Bose Public Affairs Group | $37.5K |
| 04/20for Q1 | Bose Public Affairs Group | $37.5K |
| 01/20for Q4 2025 | Bose Public Affairs Group | $30K |
| 25/10/20for Q3 2025 | Bose Public Affairs Group | $30K |
| 25/09/15for Q3 2025 | Bose Public Affairs Group | Under $5,000 |